Video

Dr. Cella on Patient Reported Data's Cost Effectiveness

Author(s):

David Cella, PhD

Dr. David Cella from Northwestern University Feinberg School of Medicine on Quality of Life Assessments' Cost Effectiveness

David Cella, PhD, a clinical research specialist and chair of the Department of Medical Social Science at Northwestern University Feinberg School of Medicine in Chicago discusses his findings on the cost effectiveness of quality of life assessments.

Related Videos
J. Bradley Elder, MD
Rimas V. Lukas, MD
Shubham Pant, MD, MBBS
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Howard S. Hochster, MD, FACP,
John H. Strickler, MD
Brandon G. Smaglo, MD, FACP
Cedric Pobel, MD
Ruth M. O’Regan, MD
Related Content
FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer
October 30th 2024

FDA Receives NDA for 3-Month Version of Leuprolide Mesylate for Advanced Prostate Cancer

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer
August 6th 2020

Dizon Discusses Elements of Sexual Health in Gynecologic Cancer

William E. Rosa, PhD, MBE, APRN, of Memorial Sloan Kettering Cancer Center
September 4th 2024

ASCO Palliative Care Expert Panel Provides Recommendations to Integrate Health Equity Into Guideline Development

Integrating Nutrition Into the Continuum of Cancer Care
June 18th 2020

Integrating Nutrition Into the Continuum of Cancer Care

Brooke Worster, MD, MS, FACP
July 31st 2024

Model Validates Cost Savings With Cannabis in Mitigating Symptoms for Patients With Cancer

Lisa Conte
July 23rd 2024

Crofelemer Misses Diarrhea End Point in Patients With Solid Tumors Receiving Targeted Therapy